Ideas to action: independent research for global prosperity
Search
Filters:
Experts
Facet Toggle
Topics
Facet Toggle
Content Type
Facet Toggle
Publication Type
Facet Toggle
Time Frame
Facet Toggle
Blog Post
January 21, 2022
Even as the fight to control COVID-19 at home is far from over, to bring an end to the pandemic, the administration must dramatically expand its global response work—and continue its efforts to rally the international community. Here we provide a rundown of the administration’s progress toward achie...
Blog Post
January 20, 2022
In the wake of the COVID-19 crisis, many sub-Saharan African countries will face serious economic crises and shrinking public spending. If countries are unable to spend more, they need to spend better. Europe has leading expertise in building institutions for priority-setting in health, making it an...
Blog Post
December 13, 2021
In the language of economists, opportunity cost refers to the return or other forms of benefit that we could have received, but gave up, to take another course of action. In mathematical terms, it is the difference between the utility of what we have chosen and that from the foregone choice. Or, in ...
Blog Post
November 24, 2021
Prolonged school closures during COVID-19 meant that over 7.7 million Malawian children were out of formal schooling for over seven months. There is little information about the impacts of school closures and the COVID-19 crisis on these individuals. What happened to student participation over the t...
Blog Post
November 04, 2021
In this blog, we provide a rapid overview of the sources and wider uses of medicines data to strengthen health systems in LMIC settings, with a focus on Ghana. We argue that having credible and comprehensive data on medicines use leads to better decision making and better medicines policy. These are...
Blog Post
November 01, 2021
Lawmakers on Capitol Hill extended a lifeline to US global response efforts with the provision of supplemental funding. Early on, sums dedicated to the overseas fight were modest, but last year's end-of-year spending package included $4 billion for Gavi, the Vaccine Alliance—to support the multilate...
Blog Post
October 28, 2021
We conducted a joint review of the portfolio management activities of the committee overseeing COVAX R&D and manufacturing investments, known as RDMIC (R&D and Manufacturing Investment Committee). Our aim was to assess learnings from investments to date and suggest ways to strengthen future ...